Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Capital Reinvestment Ratio
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Capital Reinvestment Ratio of 0.28x as of December 2024, meaning it reinvests 0% of its operating cash flow (CN¥116.38 Million) in capital expenditures (CN¥33.16 Million). See Medprin Regenerative Medical Technologie (301033) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medprin Regenerative Medical Technologies Co. Ltd. Capital Reinvestment Ratio (2019–2024)
This chart tracks Medprin Regenerative Medical Technologies Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year Capital Reinvestment Ratio for Medprin Regenerative Medical Technologies Co. Ltd. from 2019 to 2024. For live market cap and broader valuation context, see Medprin Regenerative Medical Technologie (301033) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.28x | CN¥116.38 Million | CN¥33.16 Million | ▼ -23.5% |
| 2023 | 0.37x | CN¥107.69 Million | CN¥40.09 Million | ▼ -86.8% |
| 2022 | 2.81x | CN¥48.31 Million | CN¥135.96 Million | ▲ +22.6% |
| 2021 | 2.30x | CN¥66.51 Million | CN¥152.71 Million | ▲ +26.3% |
| 2020 | 1.82x | CN¥33.91 Million | CN¥61.65 Million | ▲ +54.9% |
| 2019 | 1.17x | CN¥31.27 Million | CN¥36.71 Million | — |